Ventyx Biosciences

VTYX NASDAQ
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $0 $1,076 $0 $0
Gross Profit -408 673 -265 -139
EBITDA -41,360 -47,743 -57,951 -57,006
EBIT -41,768 -48,146 -58,216 -57,145
Net Income -38,572 -46,753 -54,027 -53,251
Net Change In Cash 0 1,076 0 0
Free Cash Flow -47,800 -51,866 -34,712 -49,477
Cash 141,898 51,579 56,610 51,717
Basic Shares 61,829 59,076 58,880 58,556

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $0 $0 $0 $0
Gross Profit -941 -470 -30
EBITDA -204,553 -108,426 -72,596 -7,051
EBIT -205,494 -113,136 -67,147 -7,050
Net Income -192,962 -107,956 -78,366 -28,532
Net Change In Cash 0 0 0 0
Cost of Revenue -5,930 70,547
Free Cash Flow -167,036 -99,046 -38,912 -6,195
Cash 51,579 64,819 70,791 244
Basic Shares 58,542 52,471 50,408 50,296

Earnings Calls

Quarter EPS
2024-03-31 -$0.62
2023-12-31 -$0.79
2023-09-30 -$0.92
2023-06-30 -$0.91